A Formulation Licence, a Silent Partner, and a Ten-Day Clock

The situation

Ten days. That was what remained on the notice-to-cure clause when Rahel called our office, licence agreement in hand, unsure whether to let the clock run out quietly or fight to keep control of a formulation she had spent six years developing.

Rahel had built a proprietary compounding process for a line of topical preparations early in her career as a pharmacist. Rather than open branch locations herself, she structured growth by licensing the formulation and its accompanying quality protocol to independent operators, each bound by a written agreement that set strict compounding standards, documentation requirements, and grounds for termination if those standards were not met. The arrangement had worked well for several years and had become a meaningful share of her company's revenue.

Two features of the structure made this dispute harder than an ordinary licence breach. First, Rahel was not the sole decision-maker. Hyun-woo, a construction project manager who had put in early capital as a minority partner in the licensing entity, held a contractual say over major steps under their shareholder arrangement, and he was already telling Rahel that ending a licence of this size fell within it. Second, the licensee in question, Haruto, operated a compounding site in another city and had already received two informal quality warnings before a formal audit found undocumented batches, missing temperature logs, and unexplained ingredient substitutions that departed from the licensed process.

Under the agreement, those findings gave Rahel grounds to terminate on notice, with a short cure period built in. Haruto disputed the audit outright, calling the visit unrepresentative and threatening to keep operating past any termination date and to sue for wrongful termination and lost income if Rahel pressed ahead. At the same time, Hyun-woo, wary of litigation cost and of losing licensing revenue from Haruto's site during a dispute, wanted to renegotiate rather than terminate, splitting the ownership group's own position before it had said a word to Haruto directly. Rahel needed to protect the formulation, protect the brand carried by every other licensee, and act inside a window that did not pause for internal disagreement. The total exposure across termination damages, disputed royalties, and the licence's remaining value sat in the mid to high hundreds of thousands. Rahel's employees, who made up a small but stable team supporting the compounding operations at her own site, were watching the dispute too; several had worked alongside her long enough to understand what the formulation meant to the business, and a drawn-out fight that damaged the brand would have touched their jobs too.

The risk we had to size

Before advising Rahel to send anything, we had to size the risk on three fronts at once, because a decision that solved one exposure could easily create another. The first risk was evidentiary: if the quality audit could not withstand challenge, terminating on it would hand Haruto a wrongful termination claim with real merit, and the whole basis for protecting the formulation would collapse. That risk was not abstract. Haruto had already retained his own counsel and floated the idea that the audit had been conducted by a technician with a personal grievance, an allegation that, if true, would have undermined the finding regardless of how solid the paperwork otherwise looked. A wrongful termination claim over a commercial licence turns on whether the terminating party actually had grounds and followed the process the agreement required; if either was shaky, Haruto would not need to disprove every finding, only enough of them to make the termination itself look like the real breach.

The second risk sat inside Rahel's own ownership structure. Hyun-woo's consent right meant that if we advised termination and Rahel proceeded without securing that consent, or without a defensible answer to why consent was not required, the termination itself could be challenged internally, on top of any fight with Haruto. We needed to read the shareholder agreement as carefully as the licence agreement, because the two documents did not use identical thresholds, and a mismatch in either direction changed what Rahel was legally free to do on her own.

The third risk was reputational and operational across the wider licensing network. Rahel had other licensees watching how this would be handled. A termination that looked rushed or unsupported would unsettle operators who were following the rules, while a termination that visibly caved to a licensee's pushback would signal that the quality standard was negotiable. Neither outcome protected the asset that made the whole business model work.

We weighed these against each other rather than treating them as separate problems. The audit needed to be defensible enough to survive a challenge from Haruto, the termination needed to be structured so it did not depend on a consent right that was contested internally, and the communication to the wider network needed to happen only once the first two were secure. Sizing the risk this way told us where to spend effort first: not on drafting a termination letter, but on making the underlying record strong enough that neither Haruto's dispute nor Hyun-woo's hesitation could unsettle it.

What we did

1. Reviewed the audit methodology before relying on it. We had the auditor walk us through exactly how the site visit was conducted, what was measured against the licensed protocol, and what documentation was compared. A termination for cause stands or falls on whether the record survives an adversarial challenge, not on how convincing it looked internally. This let us confirm the findings tracked the agreement's actual standards, which mattered once Haruto called the process unrepresentative.
2. Cross-checked the licence and shareholder agreements against each other. We mapped the termination threshold in the licence against the consent right in the shareholder agreement line by line, since the two documents used different language for similar-sounding triggers. The consent right, it turned out, applied only to granting new licences above the revenue threshold, not to terminating an existing one for cause. That distinction closed off Hyun-woo's strongest argument that his sign-off was required.
3. Secured and preserved the underlying records. We arranged for the audit photographs, batch logs, temperature records, and correspondence with Haruto to be collected, dated, and stored in a single file before any dispute made them harder to obtain. Doing this early meant the evidentiary record could not later be characterized as selectively assembled after the fact, once Haruto's own lawyer started looking for gaps in how the file had been put together.
4. Brought Hyun-woo into a structured conversation, not a vote. Rather than let the disagreement play out as an internal standoff, we set out in writing why the consent right did not apply, what the exposure looked like if the quality failure went uncorrected, and what continuing to license a non-compliant site risked for every other operator in the network. This reframed the choice for him from a veto he believed he held to a risk he had a stake in managing well.
5. Issued a termination notice built on the cure clause, not around it. The notice cited the specific standards breached, referenced the two earlier informal warnings in writing, and gave Haruto the full contractual cure period rather than a shortcut that might have looked faster but would have handed him a procedural objection. Following the clause exactly meant any later challenge would have to attack the underlying findings themselves, which were sound, rather than the way the notice had been delivered.
6. Prepared for continued operation past the notice date. Anticipating that Haruto might keep the site running regardless of the notice, since he had already threatened to do exactly that, we prepared the materials needed to seek an order requiring him to stop using the formulation and brand elements if the cure period passed without compliance. Having that application effectively ready to file meant Rahel would not lose momentum at the moment it mattered most.
7. Managed communication to the wider licensing network separately. Once the termination was issued and legally defensible, we helped Rahel prepare a short, factual notice to other licensees confirming that the formulation and quality standards remained fully protected, without disclosing the dispute's specifics or naming Haruto. Sequencing it this way avoided the risk of announcing a decision to the network and then having to walk it back if Haruto's challenge had gained any traction.
8. Kept Rahel's own staff informed at a level appropriate to their role. We advised Rahel to give her core compounding team a brief, accurate account of what was happening once the termination notice was issued, rather than letting them learn about a licensing dispute secondhand. Uncertainty about the business's stability spreads fastest through rumour, and a team that understood the outline of what was happening was better placed to stay focused while it was resolved.

The outcome

Haruto did not cure the deficiencies within the notice period and, after initially indicating he would keep operating the site, agreed to wind down use of the formulation and branding once it became clear the termination would hold up against his objections and that continued use would be actively challenged. He did not pursue the wrongful termination claim he had threatened, and no formal court proceeding was ever needed to enforce the termination itself.

Hyun-woo, once shown that his consent right did not extend to this decision and that the quality failure carried real exposure for the whole network, did not press the internal objection further. The partnership continued on the same terms it had operated under before the dispute, with no renegotiation of Rahel's authority over licence enforcement and no lasting damage to the working relationship between the two owners. That mattered as much to Rahel as the outcome with Haruto did, since the business still depended on the two of them being able to make fast decisions together on whatever came next.

Rahel retained full control of the formulation, the licence agreement's termination process was tested and held, and the wider network of licensees continued operating under the same standards without disruption. None of the other licensees needed to be told more than that a standards issue had been resolved, which kept the episode from becoming a distraction across the rest of the network. The site itself was later relicensed to a new operator under the same terms, without any renegotiation of the underlying agreement, confirming that the template Rahel had built was sound and did not need to be rewritten because of what one licensee had done.

The dispute resolved without a full trial, largely because the underlying record, the audit, the earlier warnings, and the correct reading of the shareholder agreement, was strong enough that neither party pushing back had a foothold left once it was laid out. The legal cost of reaching that point was a fraction of what a contested trial over the licence's value would have run, which mattered to Rahel directly, since every dollar spent defending the formulation was a dollar not reinvested in the business itself.

What you can learn from this